PRICE T ROWE ASSOCIATES INC /MD/ - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$923,339,000
+38.8%
5,365,133
+1.2%
0.09%
+40.3%
Q2 2021$665,073,000
-8.5%
5,299,812
-1.1%
0.06%
-15.1%
Q1 2021$726,640,000
+7.0%
5,358,304
+0.9%
0.07%
+4.3%
Q4 2020$679,331,000
+16.2%
5,309,766
+2.2%
0.07%
+2.9%
Q3 2020$584,635,000
+30.5%
5,195,373
+10.5%
0.07%
+21.4%
Q2 2020$447,971,000
+22.8%
4,702,119
+15.9%
0.06%
-3.4%
Q1 2020$364,688,000
+100.4%
4,057,954
+18.2%
0.06%
+141.7%
Q4 2019$182,004,000
+34.9%
3,432,743
+0.5%
0.02%
+26.3%
Q3 2019$134,944,000
-13.0%
3,415,437
-9.5%
0.02%
-13.6%
Q2 2019$155,041,000
-25.9%
3,774,113
-16.0%
0.02%
-29.0%
Q1 2019$209,351,000
-4.2%
4,495,413
-10.4%
0.03%
-16.2%
Q4 2018$218,432,000
-19.8%
5,015,667
+5.4%
0.04%
-7.5%
Q3 2018$272,416,000
+30.9%
4,760,028
+10.9%
0.04%
+25.0%
Q2 2018$208,189,000
+46.8%
4,290,792
+18.3%
0.03%
+39.1%
Q1 2018$141,863,000
+5.0%
3,628,222
+13.9%
0.02%
+4.5%
Q4 2017$135,162,000
+14.8%
3,184,770
+1.0%
0.02%
+10.0%
Q3 2017$117,693,000
+0.7%
3,153,619
-18.0%
0.02%
-4.8%
Q2 2017$116,908,000
+13.1%
3,846,907
-1.5%
0.02%
+10.5%
Q1 2017$103,326,000
+8.9%
3,903,525
+5.0%
0.02%0.0%
Q4 2016$94,855,000
-20.2%
3,716,879
+13.2%
0.02%
-20.8%
Q3 2016$118,876,000
+11.3%
3,284,766
+4.5%
0.02%
+4.3%
Q2 2016$106,840,000
+37.4%
3,144,199
+6.7%
0.02%
+35.3%
Q1 2016$77,775,000
-45.6%
2,947,139
+0.6%
0.02%
-43.3%
Q4 2015$142,841,000
+83.6%
2,929,479
-6.3%
0.03%
+76.5%
Q3 2015$77,813,000
-21.9%
3,125,001
-0.7%
0.02%
-15.0%
Q2 2015$99,591,000
-17.6%
3,147,643
-0.8%
0.02%
-20.0%
Q1 2015$120,815,000
-9.1%
3,174,335
-6.9%
0.02%
-10.7%
Q4 2014$132,907,000
+35.9%
3,411,375
+5.5%
0.03%
+33.3%
Q3 2014$97,828,000
-12.0%
3,235,055
-1.1%
0.02%
-12.5%
Q2 2014$111,141,000
+74.7%
3,271,727
+77.4%
0.02%
+71.4%
Q1 2014$63,613,000
+65.3%
1,843,843
+89.8%
0.01%
+250.0%
Q4 2013$38,476,000971,6000.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Polaris Venture Management Co IV LLC 1,480,060$53,563,00085.86%
NEXTHERA CAPITAL LP 217,817$7,883,0004.84%
Novo Holdings A/S 903,833$32,710,0002.90%
SECTORAL ASSET MANAGEMENT INC 481,765$17,435,0001.71%
Perceptive Advisors 589,890$21,348,0001.38%
RA Capital Management 318,565$11,529,0001.19%
OAK RIDGE INVESTMENTS LLC 1,226,468$44,386,0001.15%
Granahan Investment Management 817,149$29,573,0000.97%
Eventide Asset Management 428,900$15,522,0000.95%
QVT Financial LP 636,764$23,044,0000.87%
View complete list of ACCELERON PHARMA INC shareholders